Tumor Heterogeneity—A ‘Contemporary Concept’ Founded on Historical Insights and Predictions

Heterogeneity is commonplace in all cancer types and at several levels—intrinsic (genetic), epigenetic, positional, and at the population level. The different subpopulations with a tumor mass communicate with each other and influence the behavior of other tumor cells both locally and at a distance....

Full description

Saved in:
Bibliographic Details
Published inCancer research (Chicago, Ill.) Vol. 76; no. 1; pp. 4 - 6
Main Author Welch, Danny R.
Format Journal Article
LanguageEnglish
Published United States 01.01.2016
Subjects
Online AccessGet full text
ISSN0008-5472
1538-7445
DOI10.1158/0008-5472.CAN-15-3024

Cover

Loading…
Abstract Heterogeneity is commonplace in all cancer types and at several levels—intrinsic (genetic), epigenetic, positional, and at the population level. The different subpopulations with a tumor mass communicate with each other and influence the behavior of other tumor cells both locally and at a distance. These properties have profound implications regarding the understanding of tumor behavior and how therapies are (or should be) administered. This brief commentary highlights the insightful review of Gloria Heppner and how it has influenced cancer research even three decades after it was published. Cancer Res; 76(1); 4–6. ©2016 AACR. See related article by Heppner, Cancer Res 1984;44:2259-65.
AbstractList Heterogeneity is commonplace in all cancer types and at several levels--intrinsic (genetic), epigenetic, positional, and at the population level. The different subpopulations with a tumor mass communicate with each other and influence the behavior of other tumor cells both locally and at a distance. These properties have profound implications regarding the understanding of tumor behavior and how therapies are (or should be) administered. This brief commentary highlights the insightful review of Gloria Heppner and how it has influenced cancer research even three decades after it was published.
Heterogeneity is commonplace in all cancer types and at several levels—intrinsic (genetic), epigenetic, positional, and at the population level. The different subpopulations with a tumor mass communicate with each other and influence the behavior of other tumor cells both locally and at a distance. These properties have profound implications regarding the understanding of tumor behavior and how therapies are (or should be) administered. This brief commentary highlights the insightful review of Gloria Heppner and how it has influenced cancer research even three decades after it was published. Cancer Res; 76(1); 4–6. ©2016 AACR. See related article by Heppner, Cancer Res 1984;44:2259-65.
Author Welch, Danny R.
Author_xml – sequence: 1
  givenname: Danny R.
  surname: Welch
  fullname: Welch, Danny R.
BackLink https://www.ncbi.nlm.nih.gov/pubmed/26729788$$D View this record in MEDLINE/PubMed
BookMark eNp9kb1OwzAUhS1UREvhEUAeWQJ2YudHTFUEtFIFDGW2EtstRokdbGdg60MwwOv1SXAEZWBg8r1X37F9zzkGI220BOAMo0uMaX6FEMojSrL4spzdR5hGCYrJAZhgmuRRRggdgckvMwbHzr2ElmJEj8A4TrO4yPJ8AqpV3xoL59JLazZSS-Xfdtv3GdxtP0qjvWw7Yyv7BkPDZed32094a3otpIBGw7ly3ljFqwYutFObZ-9gpQV8tFIo7pXR7gQcrqvGydOfcwqebm9W5TxaPtwtytky4iSOfRSnCHFUICxphkVS1Ihm6xSHn4qEFBQlSYpDgUVOa1SLuK4LXmNekJyu0zBMpuDi-97OmtdeOs9a5bhsmkpL0zuGM0pQkZAMBfT8B-3rVgrWWdWGHdnelgBcfwPcGuesXDOufDWs422lGoYRG0Jgg8FsMJiFEBimbAghqOkf9f6B_3Vfu1mMcA
CitedBy_id crossref_primary_10_1002_pmic_201500424
crossref_primary_10_1158_0008_5472_CAN_16_0152
crossref_primary_10_1016_j_ctrv_2024_102843
crossref_primary_10_1016_j_phymed_2021_153830
crossref_primary_10_1002_admt_202301306
crossref_primary_10_1007_s10549_021_06472_5
crossref_primary_10_1158_1541_7786_MCR_21_0986
crossref_primary_10_1021_jacs_8b08931
crossref_primary_10_1016_j_biopha_2018_06_149
crossref_primary_10_1158_0008_5472_CAN_19_0458
crossref_primary_10_1186_s12885_020_07604_8
crossref_primary_10_31793_1680_1466_2020_25_3_227
crossref_primary_10_1039_C8NA00089A
crossref_primary_10_1186_s12935_024_03538_4
crossref_primary_10_3390_jpm10040188
crossref_primary_10_1016_j_bioadv_2023_213301
crossref_primary_10_24018_ejmed_2020_2_5_482
crossref_primary_10_2967_jnmt_121_263534
crossref_primary_10_1016_j_csbj_2019_11_009
crossref_primary_10_1017_erm_2021_5
crossref_primary_10_1016_j_bbcan_2016_11_005
crossref_primary_10_1007_s10555_022_10077_9
crossref_primary_10_3390_cancers11101574
crossref_primary_10_1038_s41416_020_01125_8
crossref_primary_10_1200_EDBK_158808
crossref_primary_10_3389_fonc_2021_762023
crossref_primary_10_1016_j_semcdb_2016_08_025
crossref_primary_10_1136_jcp_2024_209597
crossref_primary_10_3389_fonc_2022_963884
crossref_primary_10_3390_cancers12123636
crossref_primary_10_3390_cancers13236100
crossref_primary_10_1098_rsif_2017_0490
crossref_primary_10_1158_0008_5472_CAN_16_0585
crossref_primary_10_3390_ijms22105246
crossref_primary_10_1634_theoncologist_2019_0650
crossref_primary_10_1039_D1AN00751C
crossref_primary_10_1101_cshperspect_a028332
crossref_primary_10_3390_ijerph20032392
crossref_primary_10_1038_s41598_023_35313_2
crossref_primary_10_1039_D2SM00015F
crossref_primary_10_1021_acsami_3c17673
crossref_primary_10_1088_1478_3975_ab1a09
crossref_primary_10_1364_BOE_7_004007
crossref_primary_10_1038_s41556_018_0236_7
crossref_primary_10_1038_s41598_017_12557_3
crossref_primary_10_1186_s40364_024_00654_1
crossref_primary_10_1007_s13277_016_5161_4
crossref_primary_10_1158_0008_5472_CAN_17_0790
crossref_primary_10_1186_s12957_022_02615_0
crossref_primary_10_3390_cells13010003
crossref_primary_10_1097_JP9_0000000000000014
crossref_primary_10_1186_s12885_020_06807_3
crossref_primary_10_3390_cancers14030633
crossref_primary_10_1016_j_trecan_2020_02_016
crossref_primary_10_1021_envhealth_3c00132
crossref_primary_10_1002_adfm_201807553
crossref_primary_10_1021_acs_bioconjchem_0c00119
crossref_primary_10_1007_s00418_023_02258_6
crossref_primary_10_1016_j_urolonc_2018_05_008
crossref_primary_10_3389_fonc_2019_00455
crossref_primary_10_1038_s41379_022_01012_y
crossref_primary_10_1007_s10555_023_10111_4
crossref_primary_10_1016_j_prp_2023_154837
crossref_primary_10_3748_wjg_v24_i24_2567
crossref_primary_10_1007_s00216_019_01694_5
crossref_primary_10_1186_s13059_019_1830_0
crossref_primary_10_1016_j_trecan_2020_08_004
crossref_primary_10_1186_s41747_017_0006_5
crossref_primary_10_1002_path_5036
crossref_primary_10_1080_14737140_2019_1552138
crossref_primary_10_1016_j_heliyon_2024_e25570
crossref_primary_10_1042_BSR20181271
crossref_primary_10_1016_S1470_2045_18_30332_2
crossref_primary_10_1038_bjc_2017_5
crossref_primary_10_3390_cancers16050951
Cites_doi 10.1007/s10555-013-9435-7
10.1016/j.ccr.2012.03.003
10.1038/nature12624
10.1038/nature12628
10.1158/0008-5472.CAN-12-3678
10.1158/0008-5472.CAN-12-2217
10.1126/science.1256930
10.1038/onc.2014.475
10.1158/0008-5472.CAN-15-0074
10.1038/nrc3063
10.1126/science.1254257
10.1007/s10555-013-9426-8
10.1038/nrc3206
10.1038/nrc905
10.1158/0008-5472.CAN-07-5835
10.1007/BF01786761
10.1054/bjoc.2001.1743
10.1038/nrc3726
10.1002/ijc.2910450532
10.1007/s10585-008-9182-2
10.1038/nature13952
ContentType Journal Article
Copyright 2016 American Association for Cancer Research.
Copyright_xml – notice: 2016 American Association for Cancer Research.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1158/0008-5472.CAN-15-3024
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE
CrossRef
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1538-7445
EndPage 6
ExternalDocumentID 26729788
10_1158_0008_5472_CAN_15_3024
Genre Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NCI NIH HHS
  grantid: R01 CA087728
– fundername: NCI NIH HHS
  grantid: P30 CA168524
– fundername: NCI NIH HHS
  grantid: R01 CA134981
GroupedDBID ---
-ET
18M
29B
2WC
34G
39C
53G
5GY
5RE
5VS
6J9
AAFWJ
AAJMC
AAYXX
ABOCM
ACGFO
ACIWK
ACPRK
ACSVP
ADBBV
ADCOW
ADNWM
AENEX
AETEA
AFHIN
AFOSN
AFRAH
AFUMD
ALMA_UNASSIGNED_HOLDINGS
BAWUL
BTFSW
CITATION
CS3
DIK
DU5
EBS
EJD
F5P
FRP
GX1
H13
IH2
KQ8
L7B
LSO
OK1
P0W
P2P
PQQKQ
RCR
RHI
RNS
SJN
TR2
W2D
W8F
WH7
WOQ
YKV
YZZ
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c422t-2600c0901e571d39b057f61267d3495033613491d85b0bd2bb9cb1c9485f6d853
ISSN 0008-5472
IngestDate Thu Jul 10 23:09:21 EDT 2025
Thu Apr 03 06:50:31 EDT 2025
Tue Jul 01 01:40:51 EDT 2025
Thu Apr 24 23:01:13 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License 2016 American Association for Cancer Research.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c422t-2600c0901e571d39b057f61267d3495033613491d85b0bd2bb9cb1c9485f6d853
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink http://doi.org/10.1158/0008-5472.CAN-15-3024
PMID 26729788
PQID 1754093470
PQPubID 23479
PageCount 3
ParticipantIDs proquest_miscellaneous_1754093470
pubmed_primary_26729788
crossref_citationtrail_10_1158_0008_5472_CAN_15_3024
crossref_primary_10_1158_0008_5472_CAN_15_3024
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2016-01-01
2016-Jan-01
20160101
PublicationDateYYYYMMDD 2016-01-01
PublicationDate_xml – month: 01
  year: 2016
  text: 2016-01-01
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Cancer research (Chicago, Ill.)
PublicationTitleAlternate Cancer Res
PublicationYear 2016
References Gilkes (2022061704582044300_bib22) 2014; 14
Fox (2022061704582044300_bib12) 2013; 32
Meacham (2022061704582044300_bib7) 2013; 501
Klein (2022061704582044300_bib6) 2013; 501
De Jaeger (2022061704582044300_bib21) 2001; 84
Patel (2022061704582044300_bib4) 2014; 344
Lunt (2022061704582044300_bib20) 2009; 26
Welch (2022061704582044300_bib3) 1989
Skibinski (2022061704582044300_bib8) 2015; 34
Loeb (2022061704582044300_bib13) 2011; 11
Kerbel (2022061704582044300_bib23) 2002; 2
Waghorne (2022061704582044300_bib19) 1988; 48
Loeb (2022061704582044300_bib14) 2008; 68
Welch (2022061704582044300_bib2) 1985; 3
Huang (2022061704582044300_bib9) 2013; 32
Hunter (2022061704582044300_bib16) 2012; 12
Valent (2022061704582044300_bib10) 2013; 73
Feeley (2022061704582044300_bib15) 2015; 75
Heppner (2022061704582044300_bib1) 1984; 44
Swanton (2022061704582044300_bib17) 2012; 72
Price (2022061704582044300_bib18) 1990; 45
Eirew (2022061704582044300_bib24) 2015; 518
Zhang (2022061704582044300_bib5) 2014; 346
Magee (2022061704582044300_bib11) 2012; 21
3167857 - Cancer Res. 1988 Nov 1;48(21):6109-14
26471915 - Cancer Res. 2015 Oct 15;75(20):4429-36
24925914 - Science. 2014 Jun 20;344(6190):1396-401
11336482 - Br J Cancer. 2001 May 4;84(9):1280-5
22439924 - Cancer Cell. 2012 Mar 20;21(3):283-96
24048069 - Nature. 2013 Sep 19;501(7467):365-72
12360276 - Nat Rev Cancer. 2002 Oct;2(10):727-39
21593786 - Nat Rev Cancer. 2011 Jun;11(6):450-7
24827502 - Nat Rev Cancer. 2014 Jun;14(6):430-9
25703331 - Oncogene. 2015 Oct 16;34(42):5309-16
23002210 - Cancer Res. 2012 Oct 1;72(19):4875-82
18543068 - Clin Exp Metastasis. 2009;26(1):19-34
25301631 - Science. 2014 Oct 10;346(6206):256-9
22257951 - Nat Rev Cancer. 2012 Feb;12(2):144-9
2159442 - Int J Cancer. 1990 May 15;45(5):968-71
3902300 - Clin Exp Metastasis. 1985 Jul-Sep;3(3):151-88
23592419 - Cancer Metastasis Rev. 2013 Dec;32(3-4):353-61
23640024 - Cancer Metastasis Rev. 2013 Dec;32(3-4):423-48
18483233 - Cancer Res. 2008 May 15;68(10):3551-7; discussion 3557
25470049 - Nature. 2015 Feb 19;518(7539):422-6
6372991 - Cancer Res. 1984 Jun;44(6):2259-65
23345162 - Cancer Res. 2013 Feb 1;73(3):1037-45
24048065 - Nature. 2013 Sep 19;501(7467):328-37
References_xml – volume: 32
  start-page: 423
  year: 2013
  ident: 2022061704582044300_bib9
  article-title: Genetic and non-genetic instability in tumor progression: link between the fitness landscape and the epigenetic landscape of cancer cells
  publication-title: Cancer Metastasis Rev
  doi: 10.1007/s10555-013-9435-7
– volume: 21
  start-page: 283
  year: 2012
  ident: 2022061704582044300_bib11
  article-title: Cancer stem cells: impact, heterogeneity, and uncertainty
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2012.03.003
– volume: 501
  start-page: 328
  year: 2013
  ident: 2022061704582044300_bib7
  article-title: Tumour heterogeneity and cancer cell plasticity
  publication-title: Nature
  doi: 10.1038/nature12624
– volume: 501
  start-page: 365
  year: 2013
  ident: 2022061704582044300_bib6
  article-title: Selection and adaptation during metastatic cancer progression
  publication-title: Nature
  doi: 10.1038/nature12628
– volume: 73
  start-page: 1037
  year: 2013
  ident: 2022061704582044300_bib10
  article-title: Heterogeneity of neoplastic stem cells: theoretical, functional, and clinical implications
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-12-3678
– volume: 72
  start-page: 4875
  year: 2012
  ident: 2022061704582044300_bib17
  article-title: Intratumor heterogeneity: evolution through space and time
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-12-2217
– volume: 346
  start-page: 256
  year: 2014
  ident: 2022061704582044300_bib5
  article-title: Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing
  publication-title: Science
  doi: 10.1126/science.1256930
– volume: 34
  start-page: 5309
  year: 2015
  ident: 2022061704582044300_bib8
  article-title: The origin of breast tumor heterogeneity
  publication-title: Oncogene
  doi: 10.1038/onc.2014.475
– volume: 75
  start-page: 4429
  year: 2015
  ident: 2022061704582044300_bib15
  article-title: Mitochondrial genetics regulate breast cancer tumorigenicity and metastatic potential
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-15-0074
– volume: 11
  start-page: 450
  year: 2011
  ident: 2022061704582044300_bib13
  article-title: Human cancers express mutator phenotypes: origin, consequences and targeting
  publication-title: Nat Rev Cancer
  doi: 10.1038/nrc3063
– volume: 344
  start-page: 1396
  year: 2014
  ident: 2022061704582044300_bib4
  article-title: Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma
  publication-title: Science
  doi: 10.1126/science.1254257
– volume: 32
  start-page: 353
  year: 2013
  ident: 2022061704582044300_bib12
  article-title: Do mutator mutations fuel tumorigenesis?
  publication-title: Cancer Metastasis Rev
  doi: 10.1007/s10555-013-9426-8
– volume: 12
  start-page: 144
  year: 2012
  ident: 2022061704582044300_bib16
  article-title: Mouse models of cancer: does the strain matter?
  publication-title: Nat Rev Cancer
  doi: 10.1038/nrc3206
– volume: 2
  start-page: 727
  year: 2002
  ident: 2022061704582044300_bib23
  article-title: Clinical translation of angiogenesis inhibitors
  publication-title: Nat Rev Cancer
  doi: 10.1038/nrc905
– volume: 68
  start-page: 3551
  year: 2008
  ident: 2022061704582044300_bib14
  article-title: Cancers exhibit a mutator phenotype: clinical implications
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-07-5835
– volume: 3
  start-page: 151
  year: 1985
  ident: 2022061704582044300_bib2
  article-title: Implications of tumor progression on clinical oncology
  publication-title: Clin Exp Metastasis
  doi: 10.1007/BF01786761
– volume: 84
  start-page: 1280
  year: 2001
  ident: 2022061704582044300_bib21
  article-title: Relationship of hypoxia to metastatic ability in rodent tumours
  publication-title: Br J Cancer
  doi: 10.1054/bjoc.2001.1743
– volume: 14
  start-page: 430
  year: 2014
  ident: 2022061704582044300_bib22
  article-title: Hypoxia and the extracellular matrix: drivers of tumour metastasis
  publication-title: Nat Rev Cancer
  doi: 10.1038/nrc3726
– volume: 48
  start-page: 6109
  year: 1988
  ident: 2022061704582044300_bib19
  article-title: Genetic evidence for progressive selection and overgrowth of primary tumors by metastatic cell subpopulations
  publication-title: Cancer Res
– volume: 44
  start-page: 2259
  year: 1984
  ident: 2022061704582044300_bib1
  article-title: Tumor heterogeneity
  publication-title: Cancer Res
– start-page: 279
  year: 1989
  ident: 2022061704582044300_bib3
  article-title: Factors involved in the development and maintenance of tumor heterogeneity
– volume: 45
  start-page: 968
  year: 1990
  ident: 2022061704582044300_bib18
  article-title: The use of a genotypic marker to demonstrate clonal dominance during the growth and metastasis of a human breast carcinoma in nude mice
  publication-title: Int J Cancer
  doi: 10.1002/ijc.2910450532
– volume: 26
  start-page: 19
  year: 2009
  ident: 2022061704582044300_bib20
  article-title: The tumor microenvironment and metastatic disease
  publication-title: Clin Exp Metastasis
  doi: 10.1007/s10585-008-9182-2
– volume: 518
  start-page: 422
  year: 2015
  ident: 2022061704582044300_bib24
  article-title: Dynamics of genomic clones in breast cancer patient xenografts at single-cell resolution
  publication-title: Nature
  doi: 10.1038/nature13952
– reference: 18483233 - Cancer Res. 2008 May 15;68(10):3551-7; discussion 3557
– reference: 3902300 - Clin Exp Metastasis. 1985 Jul-Sep;3(3):151-88
– reference: 11336482 - Br J Cancer. 2001 May 4;84(9):1280-5
– reference: 18543068 - Clin Exp Metastasis. 2009;26(1):19-34
– reference: 21593786 - Nat Rev Cancer. 2011 Jun;11(6):450-7
– reference: 23002210 - Cancer Res. 2012 Oct 1;72(19):4875-82
– reference: 25301631 - Science. 2014 Oct 10;346(6206):256-9
– reference: 22439924 - Cancer Cell. 2012 Mar 20;21(3):283-96
– reference: 23592419 - Cancer Metastasis Rev. 2013 Dec;32(3-4):353-61
– reference: 22257951 - Nat Rev Cancer. 2012 Feb;12(2):144-9
– reference: 26471915 - Cancer Res. 2015 Oct 15;75(20):4429-36
– reference: 2159442 - Int J Cancer. 1990 May 15;45(5):968-71
– reference: 3167857 - Cancer Res. 1988 Nov 1;48(21):6109-14
– reference: 25470049 - Nature. 2015 Feb 19;518(7539):422-6
– reference: 24827502 - Nat Rev Cancer. 2014 Jun;14(6):430-9
– reference: 24048069 - Nature. 2013 Sep 19;501(7467):365-72
– reference: 24925914 - Science. 2014 Jun 20;344(6190):1396-401
– reference: 6372991 - Cancer Res. 1984 Jun;44(6):2259-65
– reference: 25703331 - Oncogene. 2015 Oct 16;34(42):5309-16
– reference: 23640024 - Cancer Metastasis Rev. 2013 Dec;32(3-4):423-48
– reference: 24048065 - Nature. 2013 Sep 19;501(7467):328-37
– reference: 23345162 - Cancer Res. 2013 Feb 1;73(3):1037-45
– reference: 12360276 - Nat Rev Cancer. 2002 Oct;2(10):727-39
SSID ssj0005105
Score 2.4737954
SecondaryResourceType review_article
Snippet Heterogeneity is commonplace in all cancer types and at several levels—intrinsic (genetic), epigenetic, positional, and at the population level. The different...
Heterogeneity is commonplace in all cancer types and at several levels--intrinsic (genetic), epigenetic, positional, and at the population level. The different...
SourceID proquest
pubmed
crossref
SourceType Aggregation Database
Index Database
Enrichment Source
StartPage 4
SubjectTerms Genetic Heterogeneity
Humans
Neoplasms - genetics
Neoplasms - pathology
Tumor Microenvironment
Title Tumor Heterogeneity—A ‘Contemporary Concept’ Founded on Historical Insights and Predictions
URI https://www.ncbi.nlm.nih.gov/pubmed/26729788
https://www.proquest.com/docview/1754093470
Volume 76
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELbKIiEuiDddHjISt5VDHuPEPlYFtAtiT7tib1HsOOLQTVZ9XDj1R3BY_l5_CePYaVJUHsslitxm3GY-z8MzniHkTWUbWKuUs1RWggHokimIFC53KKOiNCHoNkH2ND0-h48X_GI0uhpkLa2WKtDf9p4r-R-u4hjy1Z6SvQFnt0RxAO-Rv3hFDuP133i8umzmqDnw3TT4JWMr_PvkBZgcdbdipwLV1J1T7D6UrrESmp0Ig0HNkJN6Yd32hT9NYMM5_dZeX9lAm_mRrxf0tQ0Iu8yOVvLMZsFgn-GLmbmuU4izGg3_YLjfEA33GzoZKhgH13AnML3YzMAVhuzkquvrsoMfJyRhoG3T_WKcC5f36GYKppNTFnGWhDH0equL1f-izrZJhq17w4UNr4vcksmRTB7x3JK5RW7H6FhYUf7u5FOfFOSTXruZ_ZkvJPN276_ZtWZ-46K0psrZfXLP-xh04gDzgIxM_ZDc-eyzKB6RosUN3cHNZv19Qjfr6yFWqMfKZv2DepTQpqY9SmiHEooooQOUPCbnH96fTY-Zb7XBNMTxktk2BTpE29DwLCoTqdCMr9D4TbMyQRc6TJLU1rGMSsFVqMpYKalVpG1poSrFweQJOaib2jwjFHWAwgWeVgYKKGzLHRmHhYQMbVuplBkT6F5Zrn0detsOZZb_kWFjEmwfu3KFWP72wOuOHzmKTBsHK2rTrBY5WswQygSycEyeOkZtSeI_jmUmxOFNp3tO7var5QU5WM5X5iXaq0v1qoXYTx1Uiqk
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Tumor+Heterogeneity%E2%80%94A+%E2%80%98Contemporary+Concept%E2%80%99+Founded+on+Historical+Insights+and+Predictions&rft.jtitle=Cancer+research+%28Chicago%2C+Ill.%29&rft.au=Welch%2C+Danny+R.&rft.date=2016-01-01&rft.issn=0008-5472&rft.eissn=1538-7445&rft.volume=76&rft.issue=1&rft.spage=4&rft.epage=6&rft_id=info:doi/10.1158%2F0008-5472.CAN-15-3024&rft.externalDBID=n%2Fa&rft.externalDocID=10_1158_0008_5472_CAN_15_3024
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0008-5472&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0008-5472&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0008-5472&client=summon